Structural mapping and network analysis of patient-specific mutations in glioblastoma

Kaya, Tuğba
Cancer is one of the most common cause of death worldwide. It occurs as a result of a collection of somatic deviations from normal state. Therefore, many efforts have been invested to profile mutations in different types of tumors; such as, the Cancer Genome Atlas (TCGA) which deposits multiple omic data for more than 11,000 tumor samples. In this thesis, we present a pipeline which retrieves patient-specific mutation data in Glioblastoma from TCGA, maps these mutations on the protein structures in Protein Databank (PDB) and finds the location and functional effect of the mutations and reconstruct functional networks by integrating mutation data with interactome. As a result of this thesis study, we found that some mutations are specific to alternative isoform sequence of the protein instead of the canonical sequence. We also showed that functional impact of mutations in interface region is more damaging compared to the surface region and more similar to the core region of the protein. We showed that most common change in the protein core is that hydrophobic residues are mutated to another hydrophobic residue. However, in the surface or interface region a charged residue is changed either to another charged residue or a polar residue when we analyzed the chemical classes of mutations. From these mutation profiles of the patients, we reconstructed 290 GBM-specific networks with Omics Integrator which solves the prize-collecting Steiner forest (PCSF) problem and optimally connects the given set of proteins in a network context. We merged the most common nodes and edges across these patients and clustered the merged network into functional communities. The ontology and pathway enrichment analyses gave us that Wnt signaling, ERBB signaling and NfKb/Ikb signaling pathways are the most commonly enriched pathways. From mutation to protein structures and functional networks, we believe that the result of this thesis will have significant contribution in cancer research.


The Mechanism of anti tumorigenic effects of 15-lox-1 in colon cancer
Çimen, İsmail; Banerjee, Sreeparna; Department of Biology (2012)
Colorectal cancer is the 4th most widespread cause of cancer mortality. One of the pathways that are involved in the development of colorectal cancer is the arachidonic acid metabolizing lipoxygenase (LOX) pathway. Inflammatory molecules formed from this pathway exert profound effects that may exacerbate the development and progression of colon and other cancers. 15 lipoxygenase-1 (15-LOX-1) is a member of LOX protein family that metabolizes primarily linoleic acid to 13-(S)-HODE. Several lines of evidence ...
Contribution of different types of -omic data on personalized diagnosis of cancer
Tanıl, Ezgi; Kızılilsoley, Nehir; Nikerel, Emrah (Orta Doğu Teknik Üniversitesi Enformatik Enstitüsü; 2022-10)
Cancer is a complex disease which is one of the main causes of death globally. Survival rate of cancer increases if early diagnosis and application of appropriate treatment are available [1,2]. Understanding differential response from one patient to another can aid in drug targeting, understanding disease progression and finding efficient treatment strategies. Tumour cells shown to have altered metabolism and the most commonly defined example is the Warburg effect in which tumour cells shown to use lactic a...
Analyses and modeling of ovarian cancer microarray data
Karakelle, Barış S; Purutçuoğlu Gazi, Vilda; Department of Biomedical Engineering (2019)
Ovarian cancer is one of the common cancer types among other oncological diseases. The major causes of this cancer can be listed as age, obesity, hormone therapy, material inheritance and contraceptive pills. Due to its generality and importance, many researches have been conducted from distinct labs about this illness and its plausible causes have been intensively investigated either inmicroarray studies, where just part of the related genes are detected, or in thepairwise correlation analyses between the ...
Genome-wide variation analysis of formalin fixed paraffin embedded pulmonary metastatic tumor samples of osteosarcoma patients
Nil, Zelha; Gündüz, Ufuk; Department of Biology (2012)
Osteosarcoma (OS) is a type of cancer that starts in the bone. It generally occurs in the cells called osteoblasts which form matrix of the bone. It is the most common malignant tumor of bone with an incidence rate of 19% among all cancer types. The vast majority of OS patients have pulmonary metastases at the time they are diagnosed, and about half develop lung disease later. Moreover, pulmonary metastatic tumors lead to poor prognosis and increased death rate. Although mutations in the genes coding for p5...
Synthesis and biological evaluation of novel pyrazolic chalcone derivatives as novel hepatocellular carcinoma therapeutics.
Hawash, Mohammed M. A.; Kahraman, Deniz Cansen; Eren, Fikriye; Atalay, Rengül; BAYTAŞ, Sultan (2017-03-31)
Despite having the second highest mortality associated with cancer, currently Sorafenib is the only FDA-approved chemotherapeutic agent available for liver cancer patients which can only improve survival for few months. In this study, various pyrazolic chalcone analogous compounds were synthesized and evaluated as potential chemotherapeutic agents for the treatment of hepatocellular carcinoma (HCC). Modifying the central pyrazole ring at the C(3)-position with different heteroaryl rings and substituting the...
Citation Formats
T. Kaya, “Structural mapping and network analysis of patient-specific mutations in glioblastoma,” M.S. - Master of Science, Middle East Technical University, 2018.